Newman Dignan & Sheerar’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
Newman Dignan & Sheerar's ONCY Position: Q3 2025 in Review
Newman Dignan & Sheerar sold out of Oncolytics Biotech (ONCY) in Q3 2025, closing a stake of 22,915 shares — an estimated $17.7K sold.
Newman Dignan & Sheerar first reported a position in ONCY in Q3 2021 and held it in 12 quarters. The position peaked at $49.2K in Q2 2023. 56 funds tracked by Wall St. Rank hold ONCY as of Q3 2025.
- Newman Dignan & Sheerar reported no remaining Oncolytics Biotech position as of Q3 2025 after selling out during the quarter.
- Newman Dignan & Sheerar sold 22,915 Oncolytics Biotech shares in Q3 2025, an estimated $17.7K.
- Newman Dignan & Sheerar first reported a position in Oncolytics Biotech in Q3 2021 and held it in 12 quarters.
- Newman Dignan & Sheerar's Oncolytics Biotech position peaked at $49.2K in Q2 2023.
- 56 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2025.
Based on Newman Dignan & Sheerar's 13F filing for Q3 2025, filed 9 Oct 2025.